Vaccine exports lift brands presence By Liu Zhihua and Zheng Yiran | China Daily | Updated: 2021-03-08 09:08 A staff member shows CoronaVac vaccine vials at Sinovac Life Sciences in Beijing. [Photo by Chen Xiaogen/for China Daily]
Experiences accumulated from the development and export of COVID-19 vaccines will help bolster the presence of Chinese pharmaceutical, biotech and medical product companies on the world arena, business leaders and analysts said. The export of our COVID-19 vaccines helped us gain international recognition and credibility, which in turn contributed to the export of the company s other vaccine-related products, said Pearson Liu, director of brand management and public relations at Sinovac Biotech Ltd.
From:ChinaDaily | 2021-03-08 09:08
Experiences accumulated from the development and export of COVID-19 vaccines will help bolster the presence of Chinese pharmaceutical, biotech and medical product companies on the world arena, business leaders and analysts said. The export of our COVID-19 vaccines helped us gain international recognition and credibility, which in turn contributed to the export of the company s other vaccine-related products, said Pearson Liu, director of brand management and public relations at Sinovac Biotech Ltd.
For example, since 2009, Sinovac has been promoting the clinical trials and registration of its inactivated vaccine against hepatitis A in South Korea. On Dec 29, the vaccine was approved by the local medical products administration, he said.